Researchers have genetically engineered hookworms to produce human therapeutic antibodies within a host. These modified hookworms can secrete the antibodies directly into the host's bloodstream. This breakthrough offers a potential method for long-term drug delivery, possibly requiring only a single dose for years of effect. AI
RANK_REASON The cluster describes a novel research finding involving genetically engineered organisms for therapeutic purposes. [lever_c_demoted from research: ic=1 ai=0.1]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →